Recursion Pharmaceuticals Company

Founded in 2013 in Salt Lake City, Utah, Recursion is a clinical-stage AI-driven drug discovery company. It uses high-throughput imaging, machine learning, and massive biological datasets to map cellular biology and discover novel therapeutics. Its platform applies to oncology, rare disease, and aging pathways, with acquisitions including Cyclica and Valence to expand AI chemistry capabilities. (recursion.com)

Invests into

Investors

Connections from

Estimated Revenue: $58.8M (FY2024)
Founded Date: 2013
Employee Number: 500
Headquarters: 41 S Rio Grande St, Salt Lake City, UT 84101, US
Register and Claim Ownership